Cited by 916Sepsis Diagnosis and TreatmentHemodynamic Monitoring and TherapyTrauma, Hemostasis, Coagulopathy, Resuscitation

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Angiotensin II for the Treatment of Vasodilatory Shock

Open access

Khanna, Ashish, English, Shane W., Wang, Xueyuan S., Ham, Kealy, Tumlin, James, Szerlip, Harold, Busse, Laurence W., Altaweel, Laith, Albertson, Timothy E., Mackey, Caleb, McCurdy, Michael T., Boldt, David W., Chock, Stefan, Young, Paul J., Krell, Kenneth, Wunderink, Richard G., Ostermann, Marlies, Murugan, Raghavan, Gong, Michelle N., Panwar, Rakshit, Hästbacka, Johanna, Favory, Raphael, Venkatesh, Balasubramanian, Thompson, B. Taylor, Bellomo, Rinaldo, Jensen, Jeffrey, Kroll, Stew, Chawla, Lakhmir S., Tidmarsh, George F., Deane, Adam M.·2017·New England Journal of Medicine

DOI 10.1056/nejmoa1704154

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Vasodilatory shock that does not respond to high-dose vasopressors is associated with high mortality. We investigated the effectiveness of angiotensin II for the treatment of patients with this condition. METHODS: We randomly assigned patients with vasodilatory shock who were receiving more than 0.2 μg of norepinephrine per kilogram of body weight per minute or the equivalent dose of another vasopressor to receive infusions of either angiotensin II or placebo. The primary end point was a response with respect to mean arterial pressure at hour 3 after the start of infusion, with response defined as an increase from baseline of at least 10 mm Hg or an increase to at least 75 mm Hg, without an increase in the dose of background vasopressors. RESULTS: A total of 344 patients were assigned to one of the two regimens; 321 received a study intervention (163 received angiotensin II, and 158 received placebo) and were included in the analysis. The primary end point was reached by more patients in the angiotensin II group (114 of 163 patients, 69.9%) than in the placebo group (37 of 158 patients, 23.4%) (odds ratio, 7.95; 95% confidence interval [CI], 4.76 to 13.3; P<0.001). At 48 hours, the mean improvement in the cardiovascular Sequential Organ Failure Assessment (SOFA) score (scores range from 0 to 4, with higher scores indicating more severe dysfunction) was greater in the angiotensin II group than in the placebo group (-1.75 vs. -1.28, P=0.01). Serious adverse events were reported in 60.7% of the patients in the angiotensin II group and in 67.1% in the placebo group. Death by day 28 occurred in 75 of 163 patients (46%) in the angiotensin II group and in 85 of 158 patients (54%) in the placebo group (hazard ratio, 0.78; 95% CI, 0.57 to 1.07; P=0.12). CONCLUSIONS: Angiotensin II effectively increased blood pressure in patients with vasodilatory shock that did not respond to high doses of conventional vasopressors. (Funded by La Jolla Pharmaceutical Company; ATHOS-3 ClinicalTrials.gov number, NCT02338843 .).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1704154

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

APACHE II
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 15,518
APACHE II-A Severity of Disease Classification System
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,379
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure: On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine (see contributors to the project in the appendix)
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,371
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907118 · Cited by 1,940
Epidemiology of severe sepsis
Mayr, F., Yende, S. P., & Angus, D. C. (2013) · Virulence · doi:10.4161/viru.27372 · Cited by 1,298
Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*
López, A., Lorente, J. A., Steingrub, J. S., Bakker, J., McLuckie, A., Willatts, S. M., Brockway, M., Anzueto, A., Holzapfel, L., Breen, D. P., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000105581.01815.c6 · Cited by 917
Effect of Heart Rate Control With Esmolol on Hemodynamic and Clinical Outcomes in Patients With Septic Shock
Morelli, A., Ertmer, C., Westphal, M., Rehberg, S. W., Kampmeier, T., Ligges, S., Orecchioni, A., D’Egidio, A., D''Ippoliti, F., Raffone, C., et al. (2013) · JAMA · doi:10.1001/jama.2013.278477 · Cited by 739
History about the discovery of the renin-angiotensin system.
Basso, N., & Terragno, N. (2001) · HYPERTENSION · doi:10.1161/hy1201.101214 · Cited by 236
Survival After Shock Requiring High-Dose Vasopressor Therapy
Brown, S. M., Lanspa, M. J., Jones, J. P., Kuttler, K. G., Li, Y., Carlson, R., Miller, R. R., Hirshberg, E. L., Grissom, C. K., & Morris, A. H. (2013) · CHEST Journal · doi:10.1378/chest.12-1106 · Cited by 211

Flagged first, then by citations

Show all 24 references

Research works printed but not linked: 2

Chawla LS, 2017, Crit Care Resusc, 19, 43
Bassi E, 2013, Crit Care Res Pract, 2013, 654708

Sorted by citations

Items 201–300 of 916

Structural insights into GPCR signaling activated by peptide ligands: from molecular mechanism to therapeutic application
Kim, J., Kim, J., Choi, C., Bae, J., & Choi, H. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01497-y · Cited by 25
Sepsis - What's new in 2019?
Nunnally, M., & Patel, A. (2019) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000707 · Cited by 25
From a pressure-guided to a perfusion-centered resuscitation strategy in septic shock: Critical literature review and illustrative case
Gazmuri, R. J., & de Gomez, C. A. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2019.11.008 · Cited by 25
Recombinant ACE2 protein protects against acute lung injury induced by SARS-CoV-2 spike RBD protein
Zhang, L., Zhang, Y., Qin, X., Jiang, X., Zhang, J., Mao, L., Jiang, Z., Jiang, Y. L., Liu, G., Qiu, J., et al. (2022) · Critical Care · doi:10.1186/s13054-022-04034-9 · Cited by 25
How We Escalate Vasopressor and Corticosteroid Therapy in Patients With Septic Shock
Teja, B. J., Bosch, N. A., & Walkey, A. J. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.09.019 · Cited by 26
Myeloid ACE2 protects against septic hypotension and vascular dysfunction through Ang-(1–7)-Mas-mediated macrophage polarization
Li, J., Xiao, X., Teng, F., & Li, H. (2023) · Redox Biology · doi:10.1016/j.redox.2023.103004 · Cited by 25
Vasopressor Cumulative Dose Requirement and Risk of Early Death During Septic Shock: An Analysis From The EPISS Cohort
Dargent, A., Nguyen, M., Fournel, I., Bourredjem, A., Charles, P., & Quenot, J. (2017) · Shock · doi:10.1097/shk.0000000000001022 · Cited by 25
The apelinergic system as an alternative to catecholamines in low-output septic shock
Coquerel, D., Sainsily, X., Dumont, L., Sarret, P., Marsault, É., Auger‐Messier, M., & Lesur, O. (2018) · Critical Care · doi:10.1186/s13054-018-1942-z · Cited by 25
Pathophysiologic Vasodilation in Cardiogenic Shock and Its Impact on Mortality
Chavez, M. A., Anderson, M., Kyriakopoulos, C. P., Scott, M., Dranow, E., Maneta, E., Hamouche, R., Taleb, I., Leon, J., Kogelschatz, B., et al. (2024) · Circulation Heart Failure · doi:10.1161/circheartfailure.124.011827 · Cited by 24
New strategies to optimize renal haemodynamics
Suarez, J., & Busse, L. W. (2020) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000774 · Cited by 24
Self-citation
Evaluating the evidence for angiotensin II for the treatment of vasoplegia in critically ill cardiothoracic surgery patients
Chow, J. H., Wittwer, E. D., Wieruszewski, P. M., & Khanna, A. K. (2021) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.02.097 · Cited by 24
Self-citation
The medical treatment of cardiogenic shock: cardiovascular drugs
Backer, D. D., Ortiz, J. A., & Lévy, B. (2021) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000822 · Cited by 24
Echocardiographic profiles and hemodynamic response after vasopressin initiation in septic shock: A cross-sectional study
Dugar, S. P., Siuba, M., Sacha, G. L., Sato, R., Moghekar, A., Collier, P. H., Grimm, R. A., Vachharajani, V., & Bauer, S. R. (2023) · Journal of Critical Care · doi:10.1016/j.jcrc.2023.154298 · Cited by 24
A Pilot Study of Renin-Guided Angiotensin-II Infusion to Reduce Kidney Stress After Cardiac Surgery
Sadjadi, M., von Groote, T., Weiß, R., Strauß, C., Wempe, C., Albert, F., Langenkämper, M., Landoni, G., Bellomo, R., Khanna, A. K., et al. (2024) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000006839 · Cited by 24
Self-citation
Physiologic Response to Angiotensin II Treatment for Coronavirus Disease 2019–Induced Vasodilatory Shock: A Retrospective Matched Cohort Study
Leisman, D. E., Mastroianni, F., Fisler, G. M., Shah, S. S., Hasan, Z. M., Narasimhan, M., Taylor, M. D., & Deutschman, C. S. (2020) · Critical Care Explorations · doi:10.1097/cce.0000000000000230 · Cited by 24
Predictors and Impact of Prolonged Vasoplegia After Continuous-Flow Left Ventricular Assist Device Implantation
Lamba, H. K., Kim, M., Li, M., Civitello, A. B., Nair, A. P., Simpson, L., Herlihy, J. P., Frazier, O. H., Rogers, J. G., Loor, G., et al. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.100916 · Cited by 23
The Potential of Peptide-Based Inhibitors in Disrupting Protein–Protein Interactions for Targeted Cancer Therapy
Afonso, A. L., Cavaleiro, C. T., Castanho, M. A. R. B., Neves, V., & Cavaco, M. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073117 · Cited by 26
Vasopressor selection during critical care management of brain dead organ donors and the effects on kidney graft function
Swanson, E. A., Patel, M. S., Groat, T., Jameson, N. E., Ellis, M. K. M., Hutchens, M. P., Niemann, C. U., Malinoski, D., & Sally, M. B. (2020) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000002688 · Cited by 23
Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shock
Leisman, D. E., Handisides, D. R., Chawla, L. S., Albertson, T. E., Busse, L. W., Boldt, D. W., Deane, A. M., Gong, M. N., Ham, K. R., Khanna, A. K., et al. (2023) · Annals of Intensive Care · doi:10.1186/s13613-023-01227-5 · Cited by 23
Self-citation
Twenty percent human albumin solution fluid bolus administration therapy in patients after cardiac surgery-II: a multicentre randomised controlled trial
Wigmore, G. J., Deane, A. M., Presneill, J., Eastwood, G. M., Neto, A. S., Maiden, M. J., Bihari, S., Baker, R. A., Bennetts, J. S., Ghanpur, R., et al. (2024) · Intensive Care Medicine · doi:10.1007/s00134-024-07488-3 · Cited by 23
Self-citation
Intraoperative and Early Postoperative Management of Heart Transplantation: Anesthetic Implications
Neethling, E., Garijo, J. M., Mangalam, T. K., Badiwala, M., Billia, F., Wąsowicz, M., Rensburg, A. V., & Slinger, P. (2019) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2019.09.037 · Cited by 25
UNDERSTANDING HEMODYNAMIC INCOHERENCE: MECHANISMS, PHENOTYPES, AND IMPLICATIONS FOR TREATMENT
Huang, L., Huang, Q., Ma, W., & Yang, H. S. (2024) · Shock · doi:10.1097/shk.0000000000002507 · Cited by 22
Vasopressor Therapy
Vincent, J., & Annoni, F. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237372 · Cited by 22
Vasoplegic Syndrome in Cardiac Surgery: A Narrative Review of Etiologic Mechanisms and Therapeutic Options
Polyak, P., Kwak, J., Kertai, M. D., Anton, J. M., Assaad, S. I., DaCosta, M., Dimitrova, G. T., Gao, W. D., Henderson, R. A., Hollon, M., et al. (2025) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2025.02.047 · Cited by 22
Vitamin C, Hydrocortisone and Thiamine in Patients with Septic Shock (VITAMINS) trial: study protocol and statistical analysis plan
Fujii, T., Udy, A. A., Deane, A. M., Luethi, N., Bailey, M., Eastwood, G. M., Frei, D. R., French, C., Orford, N. R., Shehabi, Y., et al. (2019) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)00661-0 · Cited by 22
Self-citation
Outcome of acute kidney injury: how to make a difference?
Jamme, M., Legrand, M. M., & Géri, G. (2021) · Annals of Intensive Care · doi:10.1186/s13613-021-00849-x · Cited by 23
Recent Updates in the Pharmacological Management of Sepsis and Septic Shock: A Systematic Review Focused on Fluid Resuscitation, Vasopressors, and Corticosteroids
Allen, J. M., Feild, C. J., Shoulders, B. R., & Voils, S. A. (2018) · Annals of Pharmacotherapy · doi:10.1177/1060028018812940 · Cited by 23
Novel Vasopressors in the Treatment of Vasodilatory Shock: A Systematic Review of Angiotensin II, Selepressin, and Terlipressin
Rodriguez, R. W., Cucci, M. D., Kane, S. P., Fernandez, E. M., & Benken, S. T. (2018) · Journal of Intensive Care Medicine · doi:10.1177/0885066618818460 · Cited by 22
Cost-effectiveness of second-line vasopressors for the treatment of septic shock
Lam, S. W., Barreto, E. F., Scott, R. A., KASHANI, K. B., Khanna, A. K., & Bauer, S. R. (2019) · Journal of Critical Care · doi:10.1016/j.jcrc.2019.10.005 · Cited by 22
Self-citation
Methylene Blue for Refractory Shock in Children: A Systematic Review and Survey Practice Analysis
Luna, A. O., Johnson, R., Funaro, M. C., Canarie, M. F., & Pierce, R. W. (2020) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000002295 · Cited by 22
A Precision Medicine Approach to Biomarker Utilization in Pediatric Sepsis-Associated Acute Kidney Injury
Odum, J. D., Wong, H. R., & Stanski, N. L. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.632248 · Cited by 21
Steroids for sepsis: yes, no or maybe
Marik, P. E. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.04.35 · Cited by 22
High salt diet impairs cerebral blood flow regulation via salt‐induced angiotensin II suppression
Allen, L. A., Schmidt, J. R., Thompson, C. T., Carlson, B. E., Beard, D. A., & Lombard, J. H. (2018) · Microcirculation · doi:10.1111/micc.12518 · Cited by 21
Mineralocorticoid Dysfunction during Critical Illness
Nethathe, G. D., Cohen, J., Lipman, J., Anderson, R., & Feldman, C. H. (2020) · Anesthesiology · doi:10.1097/aln.0000000000003365 · Cited by 21
Non-catecholamine vasopressors in the treatment of adult patients with septic shock—evidence from meta-analysis and trial sequential analysis of randomized clinical trials
Zhong, L., Ji, X., Wang, H., Zhao, G., Zhou, Q., & Xie, B. (2020) · Journal of Intensive Care · doi:10.1186/s40560-020-00500-0 · Cited by 21
Angiotensin II: A Review of Current Literature
Alam, A., Sovic, W. R., Gill, J., Ragula, N., Salem, M. A., Hughes, G. J., Colbert, G. B., & Mooney, J. L. (2021) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2021.07.021 · Cited by 21
Angiotensin II
Bellomo, R., Zarbock, A., & Landoni, G. (2024) · Intensive Care Medicine · doi:10.1007/s00134-023-07290-7 · Cited by 21
Self-citation
Reduced exposure to vasopressors through permissive hypotension to reduce mortality in critically ill people aged 65 and over: the 65 RCT
Mouncey, P., Richards‐Belle, A., Thomas, K., Harrison, D. A., Sadique, Z., Grieve, R., Camsooksai, J., Darnell, R., Gordon, A. C., Henry, D., et al. (2021) · Health Technology Assessment · doi:10.3310/hta25140 · Cited by 20
Circulatory shock in adults in emergency department
Pannu, A. K. (2023) · Turkish Journal of Emergency Medicine · doi:10.4103/2452-2473.367400 · Cited by 19
Renin Levels and Angiotensin II Responsiveness in Vasopressor-Dependent Hypotension*
See, E. J., Chaba, A., Spano, S., Maeda, A., Clapham, C., Burrell, L. M., Liu, J., Khasin, M., Liskaser, G. M., Eastwood, G. M., et al. (2024) · Critical Care Medicine · doi:10.1097/ccm.0000000000006273 · Cited by 20
Self-citation
Renin in critically ill patients
Kotani, Y., Chappell, M. C., Landoni, G., Zarbock, A., Bellomo, R., & Khanna, A. K. (2024) · Annals of Intensive Care · doi:10.1186/s13613-024-01304-3 · Cited by 20
Self-citation
New drugs for acute kidney injury
Hariri, G., & Legrand, M. M. (2024) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2024.08.001 · Cited by 20
Novel Diagnostics and Therapeutics in Sepsis
Leong, K., Gaglani, B., Khanna, A. K., & McCurdy, M. T. (2021) · Biomedicines · doi:10.3390/biomedicines9030311 · Cited by 22
Self-citation
Current standard of care for septic shock
Delaney, A. P., Borges-Sa, M., Chew, M. S., Waele, J. J. D., Dye, J., Khanna, A. K., Hamzaoui, O., Hammond, N. E., Glenn Hernández, P., Herridge, M. S., et al. (2025) · Intensive Care Medicine · doi:10.1007/s00134-025-08211-6 · Cited by 19
Self-citation
Sepsis in 2018: a review
Wentowski, C. C., Mewada, N., & Nielsen, N. D. (2018) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2018.11.009 · Cited by 21
Hydroxocobalamin in Refractory Septic Shock: A Retrospective Case Series
Sacco, A. J., Cunningham, C. A., Kosiorek, H., & Sen, A. (2021) · Critical Care Explorations · doi:10.1097/cce.0000000000000408 · Cited by 19
Mean arterial pressure/norepinephrine equivalent dose index as an early measure of initiation time for enteral nutrition in patients with shock: A prospective observational study
Wang, L., Yang, H., Cheng, Y., Fu, X., Yao, H., Jin, X., Kang, Y., & Wu, Q. (2022) · Nutrition · doi:10.1016/j.nut.2021.111586 · Cited by 20
Renin as a Prognostic Marker in Intensive Care and Perioperative Settings: A Scoping Review
Kotani, Y., Belletti, A., Maiucci, G., Lodovici, M., Fresilli, S., Landoni, G., Bellomo, R., & Zarbock, A. (2023) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000006682 · Cited by 19
Self-citation
Use of Angiotensin II for Vasoplegic Shock in a Combined Heart and Liver Transplant Recipient with Systolic Anterior Motion Physiology
Wieruszewski, P. M., Sims, C. R., Daly, R. C., Taner, T., & Wittwer, E. D. (2019) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2019.03.054 · Cited by 19
Dysregulated activities of proline-specific enzymes in septic shock patients (sepsis-2)
Vliegen, G., Kehoe, K., Bracke, A., Hert, E. D., Verkerk, R. M., Fransén, E., Jongers, B. ‘., Peters, E., Lambeir, A., Kumar‐Singh, S., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231555 · Cited by 19
Fluid Resuscitation for Refractory Hypotension
Valverde, A. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.621696 · Cited by 19
Vasoplegia in Heart, Lung, or Liver Transplantation: A Narrative Review
Ortoleva, J. P., Dalia, A. A., Convissar, D. L., Pisano, D. V., Bittner, E. A., & Berra, L. M. (2025) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2025.01.012 · Cited by 18
Haemodynamic management of septic shock
Kotani, Y., Ryan, N., Udy, A. A., & Fujii, T. (2024) · Burns & Trauma · doi:10.1093/burnst/tkae081 · Cited by 18
Targeting high circulating dipeptidyl peptidase 3 in circulatory failure
Picod, A., Azibani, F., Harjola, V., Karakas, M., Kimmoun, A., Lévy, B., Pickkers, P., Thiele, H., Zeymer, U., Santos, K. F., et al. (2025) · Critical Care · doi:10.1186/s13054-025-05545-x · Cited by 18
Vasoplegia: Mechanism and Management Following Cardiopulmonary Bypass
Muhammad, R., Dharmadjati, B. B., Mulia, E. P. B., & Rachmi, D. A. (2022) · Eurasian Journal of Medicine · doi:10.5152/eurasianjmed.2022.20394 · Cited by 18
Diagnosis and Management of Vasoplegia in Temporary Mechanical Circulatory Support: A Narrative Review
Ortoleva, J. P., Dalia, A. A., Pisano, D. V., & Shapeton, A. D. (2024) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2024.02.028 · Cited by 18
How a positive fluid balance develops in acute kidney injury: A binational, observational study
White, K. C., Neto, A. S., Hurford, R., Clément, P., Laupland, K. B., Ostermann, M., Sanderson, B., Gatton, M. L., & Bellomo, R. (2024) · Journal of Critical Care · doi:10.1016/j.jcrc.2024.154809 · Cited by 18
Self-citation
Safe Use of Vasopressin and Angiotensin II for Patients with Circulatory Shock
Bauer, S. R., Sacha, G. L., & Lam, S. W. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2147 · Cited by 18
Less is more: catecholamine-sparing strategies in septic shock
Venkatesh, B., Khanna, A. K., & Cohen, J. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05770-3 · Cited by 18
Self-citation
Angiotensin II in Decompensated Cirrhosis Complicated by Septic Shock
Coleman, P. J., Nissen, A. P., Kim, D. E., Ainsworth, C., McCurdy, M. T., Mazzeffi, M. A., & Chow, J. H. (2019) · Seminars in Cardiothoracic and Vascular Anesthesia · doi:10.1177/1089253219877876 · Cited by 18
Self-citation
Activation of the angiotensin II receptor promotes autophagy in renal proximal tubular cells and affords protection from ischemia/reperfusion injury
Sugawara, H., Moniwa, N., Kuno, A., Ohwada, W., Osanami, A., Shibata, S., Kimura, Y., Abe, K., Gocho, Y., Tanno, M., et al. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.12.001 · Cited by 19
Methylene Blue for Vasoplegia During Extracorporeal Membrane Oxygenation Support
Ortoleva, J. P., Roberts, R. J., Devine, L. T., French, A. L., Kawabori, M., Chen, F., Shelton, K., & Dalia, A. A. (2020) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2020.12.042 · Cited by 18
Vasodilatory shock in the ICU and the role of angiotensin II
Wakefield, B. J., Sacha, G. L., & Khanna, A. K. (2018) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000517 · Cited by 20
Self-citation
A Retrospective Review of Angiotensin II Use in Adult Patients With Refractory Distributive Shock
Wong, A., Alkazemi, A., Eche, I. M., Petri, C. R., Sarge, T., & Cocchi, M. N. (2019) · Journal of Intensive Care Medicine · doi:10.1177/0885066619872720 · Cited by 18
Protective hemodynamics: a novel strategy to manage blood pressure
D’Amico, F., & Landoni, G. (2024) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001205 · Cited by 18
Esmolol to Treat the Hemodynamic Effects of Septic Shock: A Randomized Controlled Trial.
Cocchi, M. N., Dargin, J., Chase, M., Patel, P., Grossestreuer, A. V., Balaji, L., Liu, X., Moskowitz, A. L., Berg, K. M., & Donnino, M. W. (2022) · PubMed · doi:10.1097/shk.0000000000001905 · Cited by 17
Clinical Criteria for the Definition of Refractory Septic Shock: A Joint Delphi Consensus from the Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM)
Léone, M., Myatra, S. N., Dugar, S. P., Wieruszewski, P. M., Russell, L., Evans, L., Delamarre, L., Sharif, S., Chew, M. S., Gong, M. N., et al. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007124 · Cited by 17
Self-citation
COVID-19, what could sepsis, severe acute pancreatitis, gender differences, and aging teach us?
Gallo, C. G., Fiorino, S., Posabella, G., Antonacci, D., Tropeano, A., Pausini, E., Pausini, C., Guarniero, T., Hong, W., Giampieri, E., et al. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155628 · Cited by 17
Accuracy of Noninvasive Blood Pressure Monitoring in Critically Ill Adults
Haber, E. N., Sonti, R., Simkovich, S. M., Pike, C. W., Boxley, C. L., Fong, A., Weintraub, W. S., & Cobb, N. K. (2024) · Journal of Intensive Care Medicine · doi:10.1177/08850666231225173 · Cited by 17
Impaired angiotensin II signaling in septic shock
Picod, A., Garcia, B., van Lier, D. P. T., Pickkers, P., Herpain, A., Mebazaa, A., & Azibani, F. (2024) · Annals of Intensive Care · doi:10.1186/s13613-024-01325-y · Cited by 17
Stronger association of intact angiotensinogen with mortality than lactate or renin in critical illness: post-hoc analysis from the VICTAS trial
Chappell, M. C., Schaich, C. L., Busse, L. W., Martin, G. S., Sevransky, J., Hinson, J. S., Khanna, A. K., & Vitamin C, T. (2024) · Critical Care · doi:10.1186/s13054-024-05120-w · Cited by 17
Self-citation
Risk of Sepsis and Mortality Among Patients With Chronic Obstructive Pulmonary Disease Treated With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers
Lai, C., Wang, Y., Wang, C., Wang, H., Yu, C., & Chen, L. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003475 · Cited by 17
Angiotensin II in Vasodilatory Shock
Wakefield, B. J., Busse, L. W., & Khanna, A. K. (2019) · Critical Care Clinics · doi:10.1016/j.ccc.2018.11.003 · Cited by 17
Self-citation
Hydrocortisone in Vasodilatory Shock
Venkatesh, B., & Cohen, J. (2019) · Critical Care Clinics · doi:10.1016/j.ccc.2018.11.005 · Cited by 17
Self-citation
Angiotensin II for the treatment of distributive shock in the intensive care unit: A US cost-effectiveness analysis
Busse, L. W., Nicholson, G., Nordyke, R. J., Lee, C.-H., Zeng, F., & Albertson, T. E. (2020) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462320000082 · Cited by 17
Self-citation
Prior Exposure to Angiotensin II Receptor Blockers in Patients With Septic Shock to Individualize Mean Arterial Pressure Target? A Post Hoc Analysis of the Sepsis and Mean Arterial Pressure (SEPSISPAM) Trial*
Demiselle, J., Seegers, V., Lemerle, M., Meziani, F., Grelon, F., Mégarbane, B., Anguel, N., Mira, J. P., Dequin, P., Gergaud, S., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000004872 · Cited by 17
Glucocorticoid and mineralocorticoid receptor expression in critical illness: A narrative review
Vassiliou, A. G., Athanasiou, N., Vassiliadi, D. A., Jahaj, E., Keskinidou, C., Kotanidou, Α., & Dimopoulou, I. (2021) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v10.i4.102 · Cited by 19
Methylene blue for vasodilatory shock in the intensive care unit: a retrospective, observational study
Naoum, E. E., Dalia, A. A., Roberts, R. J., Devine, L. T., & Ortoleva, J. P. (2022) · BMC Anesthesiology · doi:10.1186/s12871-022-01739-w · Cited by 17
Machine learning models to predict 30-day mortality for critical patients with myocardial infarction: a retrospective analysis from MIMIC-IV database
Lin, X., Pan, X., Yang, Y., Yang, W., Wang, X., Zou, K., Wang, Y., Xiu, J., Yu, P., Lü, J., et al. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1368022 · Cited by 16
Self-citation
An index of the initial blood pressure response to angiotensin II treatment and its association with clinical outcomes in vasodilatory shock
Leisman, D. E., Wieruszewski, P. M., Busse, L. W., Chawla, L. S., Hibbert, K. A., Handisides, D. R., Khanna, A. K., Ostermann, M., McCurdy, M. T., Adams, C., et al. (2025) · Critical Care · doi:10.1186/s13054-025-05311-z · Cited by 16
Self-citation
Controversies in Sepsis Management—What is the Way Forward?
Lo, A. H., Kee, A. C. L., Li, A., & Rubulotta, F. M. (2020) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.202090 · Cited by 16
The evolution of mean arterial pressure in critically ill patients on vasopressors before and during a trial comparing a specific mean arterial pressure target to usual care
Masse, M.-H., Adhikari, N. K. J., Théroux, X., Battista, M., D’Aragon, F., Pinto, R. L., Cohen, A. A., Mayette, M., St-Arnaud, C., Kho, M. E., et al. (2022) · BMC Anesthesiology · doi:10.1186/s12871-021-01529-w · Cited by 16
Comprehensive Management of Blood Pressure in Patients with Septic AKI
Deng, J., Li, L., Feng, Y., & Yang, J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12031018 · Cited by 16
Trajectory of PaO 2 /FiO 2 Ratio in Shock After Angiotensin II
Wieruszewski, P. M., Coleman, P. J., Levine, A. R., Davison, D. L., Smischney, N. J., Kethireddy, S., Guo, Y., Hecht, J. P., Mazzeffi, M. A., & Chow, J. H. (2023) · Journal of Intensive Care Medicine · doi:10.1177/08850666231174870 · Cited by 16
Acute kidney injury after cardiac surgery
von Groote, T., Sadjadi, M., & Zarbock, A. (2023) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000001320 · Cited by 16
Angiotensin II in liver transplantation (AngLT-1): protocol of a randomised, double-blind, placebo-controlled trial
Bokoch, M. P., Tran, A. T., Brinson, E. L., Marcus, S. G., Reddy, M., Sun, E., Roll, G. R., Pardo, M., Fields, S., Adelmann, D., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-078713 · Cited by 16
Vasoconstriction in septic shock
Backer, D. D., Hajjar, L. A., & Monnet, X. (2024) · Intensive Care Medicine · doi:10.1007/s00134-024-07332-8 · Cited by 16
Low-Dose Continuous Kidney Replacement Therapy and Mortality in Critically Ill Patients With Acute Kidney Injury: A Retrospective Cohort Study
Okamoto, K., Fukushima, H., Kawaguchi, M., & Tsuruya, K. (2024) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2024.01.526 · Cited by 16
Higher circulating ACE2 and DPP3 but reduced ACE and angiotensinogen in hyperreninemic sepsis patients
Chappell, M. C., Schaich, C. L., Busse, L. W., Files, D. C., Martin, G. S., Sevransky, J., Hinson, J. S., Rothman, R. E., Khanna, A. K., & Vitamin C, T. A. S. I. S. (. I. (2024) · Clinical Science · doi:10.1042/cs20242168 · Cited by 16
Self-citation
Septic shock resuscitation in the first hour
Simpson, N., Lamontagne, F., & Shankar‐Hari, M. (2017) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000460 · Cited by 16
Effectiveness of Angiotensin II for Catecholamine Refractory Septic or Distributive Shock on Mortality: A Propensity Score Weighted Analysis of Real-World Experience in the Medical ICU
Quan, M., Cho, N., Bushell, T., Mak, J., Nguyen, N., Litwak, J., Rockwood, N., & Nguyen, H. B. (2022) · Critical Care Explorations · doi:10.1097/cce.0000000000000623 · Cited by 16
Angiotensin II infusion in COVID‐19: An international, multicenter, registry‐based study
Neto, A. S., Landoni, G., Ostermann, M., Lumlertgul, N., Forni, L. G., Alvarez‐Belon, L., Trapani, T. V., Alliegro, P. V., Zacharowski, K. D., Wiedenbeck, C., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27592 · Cited by 16
Self-citation
Derivation and Validation of Vasoactive Inotrope Score Trajectory Groups in Critically Ill Children With Shock
Perizes, E. N., Chong, G., & Sanchez-Pinto, L. N. (2022) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000003070 · Cited by 16
Plasma Renin Activity Increases With Cardiopulmonary Bypass and is Associated With Vasoplegia After Cardiac Surgery
Montgomery, M. L., Gross, C. R., Lin, H., Ouyang, Y., Levin, M. A., Corkill, H. E., El‐Eshmawi, A., Adams, D. H., & Weiner, M. M. (2022) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2022.11.019 · Cited by 16
Esmolol infusion in patients with septic shock and tachycardia: a prospective, single-arm, feasibility study
study, T. E. T. C. A. S. I. S. S.-R.-I. (.-R., Brown, S. M., Beesley, S. J., Lanspa, M. J., Grissom, C. K., Wilson, E. L., Parikh, S. M., Sarge, T., Talmor, D. S., Banner‐Goodspeed, V., et al. (2018) · Pilot and Feasibility Studies · doi:10.1186/s40814-018-0321-5 · Cited by 17
Self-citation
Characteristics and Outcomes of Patients With and Without Type 2 Diabetes Mellitus and Pulmonary Sepsis
Sathananthan, M., Sathananthan, A., & Jeganathan, N. (2019) · Journal of Intensive Care Medicine · doi:10.1177/0885066619833910 · Cited by 16
Angiotensin II and Vasopressin for Vasodilatory Shock: A Critical Appraisal of Catecholamine-Sparing Strategies
Heavner, M. S., McCurdy, M. T., Mazzeffi, M. A., Galvagno, S. M., Tanaka, K. A., & Chow, J. H. (2020) · Journal of Intensive Care Medicine · doi:10.1177/0885066620911601 · Cited by 16
Self-citation
Tissue Perfusion and Prognosis in the Critically Ill—Is Renin the New Lactate?*
Khanna, A. K. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003582 · Cited by 16
Self-citation
Early Multimodal Vasopressors—Are We Ready for It?*
Wieruszewski, P. M., & Khanna, A. K. (2022) · Critical Care Medicine · doi:10.1097/ccm.0000000000005344 · Cited by 16
Self-citation
Vasoplegia Syndrome After Cardiac Surgery
Castagna, F., Mehra, M. R., Nabzdyk, C. S., & Givertz, M. M. (2025) · JACC Heart Failure · doi:10.1016/j.jchf.2025.02.028 · Cited by 18

Authors: Khanna, A., English, S. W., Wang, X. S., Ham, K., Tumlin, J., Szerlip, H., Busse, L. W., Altaweel, L., Albertson, T. E., Mackey, C., McCurdy, M. T., Boldt, D. W., Chock, S., Young, P. J., Krell, K., Wunderink, R. G., Ostermann, M., Murugan, R., Gong, M. N., Panwar, R., Hästbacka, J., Favory, R., Venkatesh, B., Thompson, B. T., Bellomo, R., Jensen, J., Kroll, S., Chawla, L. S., Tidmarsh, G. F., & Deane, A. M.
Affiliations: Cleveland Clinic (US)
Regions Hospital (US)
Inova Health System (US)
Albert Einstein College of Medicine (US)
University of Maryland, Baltimore (US)
Northwestern University (US)
ORCID: Khanna, Ashish
English, Shane W.
Ham, Kealy
Szerlip, Harold
Busse, Laurence W.
Albertson, Timothy E.
McCurdy, Michael T.
Young, Paul J.
Wunderink, Richard G.
Ostermann, Marlies
Murugan, Raghavan
Gong, Michelle N.
Panwar, Rakshit
Hästbacka, Johanna
Venkatesh, Balasubramanian
Thompson, B. Taylor
Bellomo, Rinaldo
Chawla, Lakhmir S.
Deane, Adam M.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2017-08-03
Volume: 377
Issue: 5
Pages: 419-430
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1704154
OpenAlex: W2614578436
Cited by: 916
References: 24
Citations by year: 2026: 100 · 2025: 103 · 2024: 121 · 2023: 103 · 2022: 90 · 2021: 95 · 2020: 123 · 2019: 80 · 2018: 75 · 2017: 25
FWCI: 64.87
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
ePrints Soton (University of Southampton) (submittedVersion)
Figshare (submittedVersion)
Työväentutkimus Vuosikirja (submittedVersion)
Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
NOVA (University of Newcastle Australia) (submittedVersion)
Funders: Bristol-Myers Squibb
GlaxoSmithKline
La Jolla Pharmaceutical Company
Alexion Pharmaceuticals
Regeneron Pharmaceuticals
Genentech
Topics: Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Trauma, Hemostasis, Coagulopathy, Resuscitation
Keywords: angiotensin II, vasodilatory shock, septic shock, vasopressors, norepinephrine, mean arterial pressure, SOFA score, mortality, blood pressure response, adverse events, sepsis treatment, vasopressor-refractory shock, fluid resuscitation, vasopressor dose reduction, organ dysfunction, 28-day mortality
MeSH terms: Aged, Angiotensin II, Blood Pressure, Catecholamines, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Hypotension, Male, Middle Aged, Shock, Vasoconstrictor Agents, Organ Dysfunction Scores

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Angiotensin II for the Treatment of Vasodilatory Shock

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks